JHD
NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2
Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2
Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
Recent CLSD News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:06:09 PM
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process • GlobeNewswire Inc. • 11/24/2025 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2025 11:24:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2025 11:16:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2025 08:30:28 PM
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress • GlobeNewswire Inc. • 08/26/2025 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:05:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/04/2025 12:00:10 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/25/2025 08:11:36 PM
- Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery • IH Market News • 07/23/2025 12:08:34 PM
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada • GlobeNewswire Inc. • 07/23/2025 11:05:00 AM
- Clearside Biomedical shares dip after announcing exploration of strategic alternatives • IH Market News • 07/17/2025 12:38:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2025 11:15:26 AM
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline • GlobeNewswire Inc. • 07/17/2025 11:05:00 AM
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting • GlobeNewswire Inc. • 06/17/2025 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 08:05:12 PM
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum • GlobeNewswire Inc. • 05/21/2025 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:10:10 PM
- Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2025 08:05:00 PM
- Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting • GlobeNewswire Inc. • 05/09/2025 11:05:00 AM
- Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 • GlobeNewswire Inc. • 05/08/2025 11:05:00 AM
- Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 05/01/2025 11:05:00 AM
